Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ramya Movva"'
Autor:
Josephine S. F. Chow, Neil Boudville, Yeoungjee Cho, Suetonia Palmer, Elaine M. Pascoe, Carmel M. Hawley, Donna M. Reidlinger, Laura E. Hickey, Ruth Stastny, Andrea Valks, Liza Vergara, Ramya Movva, Charani Kiriwandeniya, Hayley Candler, Gabor Mihala, Bernadette Buisman, Keri-Lu Equinox, Ana E. Figueiredo, Trudi Fuge, Kirsten Howard, Martin Howell, Allison Jaure, Matthew D. Jose, Anna Lee, Susana S. Miguel, Jo-anne Moodie, Thu T. Nguyen, Geraldine Pinlac, Annie Reynolds, Walaa W. M. Saweirs, Genevieve Z. Steiner-Lim, Bronwen TeWhare, Melinda Tomlins, Megan Upjohn, David Voss, Rachael C. Walker, Joanne Wilson, David W. Johnson
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-16 (2023)
Abstract Background Peritoneal dialysis (PD)-related infections, such as peritonitis, exit site, and tunnel infections, substantially impair the sustainability of PD. Accordingly, PD-related infection is the top-priority research outcome for patients
Externí odkaz:
https://doaj.org/article/1579c83aac2441a5936bcb89799e605f
Autor:
Ramya Movva, Nida Murtaza, Rabina Giri, Chin Wen Png, Julie Davies, Saleh Alabbas, Iulia Oancea, Páraic O'Cuiv, Mark Morrison, Jakob Begun, Timothy H. Florin
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 3, Pp 359-374 (2022)
Background and Aims: There is clinical interest in the sustainability or otherwise of prebiotic, microbial, and antibiotic treatments to both prevent and treat inflammatory bowel diseases. This study examined the role of antibiotic manipulation of th
Externí odkaz:
https://doaj.org/article/1c205f339420446d94e162e8111db893
Autor:
Yong Hua Sheng, Rabina Giri, Julie Davies, Veronika Schreiber, Saleh Alabbas, Ramya Movva, Yaowu He, Andy Wu, John Hooper, Brett McWhinney, Iulia Oancea, Gregor Kijanka, Sumaira Hasnain, Andrew J. Lucke, David P. Fairlie, Michael A. McGuckin, Timothy H. Florin, Jakob Begun
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 11, Iss 1, Pp 33-53 (2021)
Background & Aims: Chronic bowel inflammation increases the risk of colon cancer; colitis-associated cancer (CAC). Thiopurine treatments are associated with a reduction in dysplasia and CAC in inflammatory bowel disease (IBD). Abnormal Wnt/β-catenin
Externí odkaz:
https://doaj.org/article/89948fa3daa4489086e5c513772d4acd
Publikováno v:
Journal of Advanced Pharmaceutical Technology & Research, Vol 6, Iss 4, Pp 190-194 (2015)
The study is aimed to assess the incidence of drug-related problems (DRPs) and provide pharmacist interventions for identified DRPs. A prospective, observational study was conducted among 189 patients with cardiovascular disease who were aged 18 year
Externí odkaz:
https://doaj.org/article/7894f30366574cbe879652e254543792
Autor:
Iulia Oancea, Andy Wu, Michael A. McGuckin, Sumaira Z. Hasnain, Rabina Giri, John D. Hooper, Veronika Schreiber, Brett C McWhinney, Julie M. Davies, Jakob Begun, Yonghua Sheng, David P. Fairlie, Saleh Y. Alabbas, Gregor Kijanka, Yaowu He, Ramya Movva, Andrew J. Lucke, Timothy H. Florin
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 11, Iss 1, Pp 33-53 (2021)
Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology
Background & Aims Chronic bowel inflammation increases the risk of colon cancer; colitis-associated cancer (CAC). Thiopurine treatments are associated with a reduction in dysplasia and CAC in inflammatory bowel disease (IBD). Abnormal Wnt/β-catenin
Publikováno v:
Gut Microbes. 9:175-178
Thiopurines are analogues of endogenous purines. They are pro-drugs which require the purine salvage pathway to convert them to the active drug nucleotides (TGN). These drugs are used to maintain clinical remission in patients with inflammatory bowel
Publikováno v:
Journal of Digestive Diseases. 18:529-536
OBJECTIVE: The potential therapeutic effect of thioguanine in the management of inflammatory bowel disease (IBD) is hindered due to association with vascular hepatotoxicity. The study aimed to assess the evidence for efficacy of thioguanine in IBD ma
Publikováno v:
Journal of Microbiological Methods. 128:102-107
Thiopurines are anti-inflammatory prodrugs. We hypothesised that bacteria may contribute to conversion to active drug. Escherichia coli strain DH5α was evaluated to determine whether it could metabolise the thiopurine drugs, thioguanine or mercaptop
Autor:
Brittney S. Harrington, Michael Lobb, Iulia Oancea, Martina Proctor, Jakob Begun, Ran Wang, Yonghua Sheng, D. Aguirre de Cárcer, Páraic Ó Cuív, Veronika Schreiber, Y. Yang, John A. Duley, Ramya Movva, Amy S. Purdon, Timothy H. Florin, Indrajit Das, Rohan Lourie
Publikováno v:
Gut
Objective Mercaptopurine (MP) and pro-drug azathioprine are ‘first-line’ oral therapies for maintaining remission in IBD. It is believed that their pharmacodynamic action is due to a slow cumulative decrease in activated lymphocytes homing to inf
Publikováno v:
Journal of digestive diseases. 18(9)
The potential therapeutic effect of thioguanine in the management of inflammatory bowel disease (IBD) is hindered due to association with vascular hepatotoxicity. The study aimed to assess the evidence for efficacy of thioguanine in IBD management an